We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.47B
AUM Growth
+$214M
Cap. Flow
+$244M
Cap. Flow %
5.46%
Top 10 Hldgs %
56.7%
Holding
106
New
9
Increased
24
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$117M
2
ZTO icon
ZTO Express
ZTO
+$81.4M
3
B
Barrick Mining
B
+$58.6M
4
MOMO
Hello Group
MOMO
+$43.8M
5
WUBA
58.com Inc
WUBA
+$27.2M

Sector Composition

Rank Sector Weight
1 Communication Services 25.75%
2 Technology 20.29%
3 Consumer Discretionary 17.17%
4 Industrials 14.18%
5 Energy 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
51
Microsoft
MSFT
$3.71T
$3.48M 0.08%
24,998
-837
-3% -$115K
CHRS icon
52
Coherus Oncology
CHRS
$196M
$3.41M 0.08%
168,237
DNTH icon
53
Dianthus Therapeutics
DNTH
$6.09B
$2.69M 0.06%
16,403
+2,243
+16% +$426K
MRUS
54
DELISTED
Merus
MRUS
$2.48M 0.06%
139,100
-37,735
-21% -$619K
BITA
55
DELISTED
Bitauto Holdings Limited
BITA
$2.44M 0.05%
162,911
NSTG
56
DELISTED
NanoString Technologies, Inc.
NSTG
$2.38M 0.05%
110,125
-27,990
-20% -$743K
RVTY icon
57
Revvity
RVTY
$12.8B
$2.33M 0.05%
27,347
-5,628
-17% -$492K
LRCX icon
58
Lam Research
LRCX
$390B
$2.29M 0.05%
99,310
-11,380
-10% -$239K
JNJ icon
59
Johnson & Johnson
JNJ
$625B
$2.16M 0.05%
16,661
+3,382
+25% +$446K
XLRN
60
DELISTED
Acceleron Pharma
XLRN
$2.03M 0.05%
51,489
AERI
61
DELISTED
Aerie Pharmaceuticals
AERI
$1.97M 0.04%
102,649
+48,265
+89% +$1.11M
MRK icon
62
Merck
MRK
$318B
$1.86M 0.04%
23,153
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.82M 0.04%
22,655
MDCO
64
DELISTED
Medicines Co
MDCO
$1.8M 0.04%
36,053
-10,760
-23% -$429K
CSCO icon
65
Cisco
CSCO
$479B
$1.76M 0.04%
35,700
AAPL icon
66
Apple
AAPL
$4.57T
$1.72M 0.04%
30,720
PYPL icon
67
PayPal
PYPL
$50.5B
$1.7M 0.04%
16,437
LIVN icon
68
LivaNova
LIVN
$4.2B
$1.68M 0.04%
22,698
AGIO icon
69
Agios Pharmaceuticals
AGIO
$1.93B
$1.66M 0.04%
51,083
+13,647
+36% +$565K
ORCL icon
70
Oracle
ORCL
$423B
$1.62M 0.04%
29,418
MYOV
71
DELISTED
Myovant Sciences Ltd.
MYOV
$1.56M 0.04%
300,616
+62,218
+26% +$462K
SGMO
72
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.53M 0.03%
168,585
PRTA icon
73
Prothena Corp
PRTA
$450M
$1.49M 0.03%
189,991
WVE icon
74
Wave Life Sciences
WVE
$1.2B
$1.46M 0.03%
70,942
SGEN
75
DELISTED
Seagen Inc. Common Stock
SGEN
$1.42M 0.03%
16,660

Similar funds

Platinum Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Platinum Investment Management held 106 positions worth $4.47B, up 5% from $4.25B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Platinum Investment Management deployed $244M of net new capital in Q3 2019, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Trip.com Group: 425,412 shares worth $12.5M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $40.6M trimmed.

  • Platinum Investment Management's largest Q3 2019 buy was Trip.com Group: 425,412 shares worth $12.5M.
  • Platinum Investment Management added most to Alibaba in Q3 2019, an estimated $117M increase.
  • Platinum Investment Management's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $40.6M.
  • Platinum Investment Management fully exited Owens Corning in Q3 2019, selling an estimated $91.9M.
  • Platinum Investment Management's ten largest holdings make up 57% of its $4.47B portfolio in Q3 2019.
  • Platinum Investment Management opened 9 new positions and closed 7 in Q3 2019.
  • Platinum Investment Management's portfolio value rose 5% quarter-over-quarter to $4.47B.

Based on Platinum Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.